CTLA-4 expression is also downregulated in Tregs from RA patients (Aldridge et al., 2021), which results in decreased co-stimulation and antigen presentation, indicating that the CTLA‐4–mediated cell cycle arrest of APCs by Tregs is also weakened. The gene discussed is CTLA4; the disease is rheumatoid arthritis.